Search

The search for common agreement between stakeholders is one of the biggest challenges when solving environmental problems. There are different views, perceptions, knowledge, and sectoral goals for these stakeholders. In complex environmental problems, such as the management of pharmaceutical micropollutants, it is essential to establish the intersectoral and individual sector priorities for a collective approach to the problem. This research aimed to identify the priority micropollutants for intervention initiatives and the management goals of the stakeholders involved in the "product chain" of pharmaceuticals in the region of Curitiba, Brazil. First, the most consumed pharmaceutical micropollutants in the region and those previously detected in water were identified, and a "long list" of 40 pharmaceuticals was drawn up for stakeholder prioritization. Stakeholders of the region were selected by intentional sampling and were invited to a workshop that was designed to list, by consensus, the priority micropollutants and objectives for their management. The event was attended by 37 stakeholders from different sectors. It was divided into 2 stages: the 1st stage was a multisectoral discussion to select the priority pharmaceutical micropollutants; the 2nd stage was a sectoral discussion to establish management objectives to control and reduce the presence of these pollutants in waters. The meeting generated a coherent prioritization of pharmaceuticals where ethinyl estradiol, ciprofloxacin, ibuprofen, diclofenac, estradiol, caffeine, and fluoxetine were prioritized and their importance was justified. The main sectoral goals prioritized were related to the drug take‐back program, the characterization of the presence of pharmaceuticals in the sanitation cycle, and the creation of a permanent multisector discussion environment for the theme. The multisectoral definition, established by consensus, of management priorities is promising and this strategic approach can be replicated in other developing countries. Integr Environ Assess Manag 2020;16:955–967. © 2020 SETAC KEY POINTS: A collective approach was developed to prioritize the management of pharmaceutical micropollutants with stakeholders involved in the product chain.We identified the priority pharmaceuticals micropollutants for intervention initiatives, where ethinyl estradiol, ciprofloxacin, ibuprofen, diclofenac, estradiol, caffeine, and fluoxetine were prioritized and their importance was justified.The main sectoral goals prioritized were related to the drug take‐back program, characterization of the presence of pharmaceuticals in the sanitation cycle, and the creation of a permanent multi‐sector discussion environment for the pharmaceutical micropollutants.The approach has shown promise for developing countries, such as those in Latin America, which are generally still taking the first steps toward managing the pharmaceutical micropollutants. [ABSTRACT FROM AUTHOR]

Copyright of Revista Ambiente e Água is the property of Revista Ambiente e Agua and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)